(Q34276981)

1 August 2017

1 reference

title

Diabetes mellitus and diabetes-associated vascular disease (English)

1 reference

1 August 2017

Kirpichnikov D

1

1 reference

1 August 2017

Sowers JR

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Trends in Endocrinology and Metabolism

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

225-230

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Diabetes mellitus and cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Risk Factors for Stroke in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Sex differences in cardiac arrest survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Glucose tolerance and blood pressure: long term follow up in middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Insulin resistance and systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Insulin, cation metabolism and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Cross-talk between the insulin and angiotensin signaling systems

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

The post-prandial state and cardiovascular disease: relevance to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Nitric oxide and vascular responses in Type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

The in vitro effects of captopril on the levels of lipid peroxidation and glutathione of erythrocytes in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900391-5

7 January 2021

10.1016/S1043-2760(01)00391-5

Identifiers

DOI

1 reference

1 August 2017

1 reference